Related references
Note: Only part of the references are listed.Parathyroid Hormone (1-34) Augments Spinal Fusion, Fusion Mass Volume, and Fusion Mass Quality in a Rabbit Spinal Fusion Model
Padhraig F. O'Loughlin et al.
SPINE (2009)
Effect of Systemic Intermittent Administration of Human Parathyroid Hormone (RHPTH[1–34]) on the Resistance to Reverse Torque in Rabbit Tibiae
Marcelo Soeiro Corsini et al.
Journal of Oral Implantology (2008)
Another option to treat Kummell's disease with cord compression
Kung-Chia Li et al.
EUROPEAN SPINE JOURNAL (2007)
The intravertebral vacuum phenomen as specific sign of osteonecrosis in vertebral compression fractures:: results from a radiological and histological study
Martin Libicher et al.
EUROPEAN RADIOLOGY (2007)
Resolution of bisphosphonate-associated osteonecrosis of the mandible: Possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]
Richard P. Harper et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2007)
Reduced risk of back pain following teriparatide treatment: a meta-analysis
MC Nevitt et al.
OSTEOPOROSIS INTERNATIONAL (2006)
The vacuum cleft sign: an uncommon radiological sign
M Sarli et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Percutaneous vertebroplasty: Treatment of painful vertebral compression fractures with intraosseous vacuum phenomena
WCG Peh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Intravertebral clefts in osteoporotic vertebral compression fractures
F McKiernan et al.
ARTHRITIS AND RHEUMATISM (2003)
The dynamic mobility of vertebral compression fractures
F McKiernan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
